RBC Capital Maintains Outperform on NOV, Raises Price Target to $19
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
RBC Capital analyst Keith Mackey maintains NOV (NYSE:NOV) with a Outperform and raises the price target from $17 to $19.
RBC Capital analyst Keith Mackey maintains NOV (NYSE:NOV) with a Outperform and raises the price target from $17 to $19.